SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001640455-22-000072
Filing Date
2022-06-28
Accepted
2022-06-28 21:06:15
Documents
1
Period of Report
2022-06-24

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_165646475914296.html 4  
1 FORM 4 wf-form4_165646475914296.xml 4 4154
  Complete submission text file 0001640455-22-000072.txt   5529
Mailing Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139 857-259-3840
Jounce Therapeutics, Inc. (Issuer) CIK: 0001640455 (see all company filings)

IRS No.: 454870634 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O JOUNCE THERAPEUTICS, INC. 1030 MASSACHUSETTS AVENUE BOSTON MA 02210
Business Address
Kamen Robert (Reporting) CIK: 0001693540 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37998 | Film No.: 221051580